PAAM Hybrid 2023

Back
02 - 04 November 2023 Porto, Portugal

Dupilumab improves histologic and endoscopic outcomes in children aged 1–11 with eosinophilic esophagitis: Results from Part A of the Phase 3 EoE KIDS study

Thursday 02 Nov, 15:29 PM - 15:41 PM Porto/Portugal (CET -1)